Objective:There has been an increasing interest in recent years in the role of stem cells.With an extensive understanding of their biology,a major role for stem cells in the malignant process has been proposed and th...Objective:There has been an increasing interest in recent years in the role of stem cells.With an extensive understanding of their biology,a major role for stem cells in the malignant process has been proposed and the existence of cancer stem cells(CSCs) has been confirmed in hematopoietic malignancies and solid organ malignancies including brain cancer,breast,prostate,colon,and pancreatic cancer.Lung cancer is the leading cause of cancer mortality in most large cities of China.It is possible that lung cancer contains cancer stem cells responsible for its malignancy.The aim of this study is to identify,characterize and enrich the CSC population that drives and maintains lung adenocarcinoma growth and metastasis.Methods:Side population(SP) cell analysis and sorting were applied on human lung adenocarcinoma cell line and an attempt to further enrich them by preliminary serum-free culture before fluorescence activated cell sorting(FACS) was done.Stem cell properties of SP cells were evaluated by their proliferative index,colony-forming efficiency,tumorigenic potential,bi-differentiation capacity and the expression of common stem cell surface markers.Results:Lung cancer cells could grow in a serum-free Medium(SFM) as non-adherent spheres similar to neurospheres or mammospheres.The proportion of SP cells in cell spheres was significantly higher than that in cells grown as monolayers.SP cells had a greater proliferative index,a higher colony-forming efficiency and a greater ability to form tumor in vivo.SP cells were both CCA positive and SP-C positive while non-SP cells were only SP-C positive.Flow cytometric analysis of cell phenotype showed that SP cells expressed CD133 and CD44,the common cell surface markers of cancer stem cells,while non-SP cells only expressed CD44.Conclusion:SP cells existed in human lung adenocarcinoma cell lines and they could be further enriched by preliminary serum-free culture before FACS sorting.SP cells possessed the properties of cancer stem cells.展开更多
目的:研究腺病毒介导的肿瘤生长抑制因子4(inhibitor of growth family 4,ING4)联合放疗对肺腺癌SPC-A1细胞移植瘤生长的抑制作用。方法:制备SPC-A1细胞荷瘤小鼠模型,随机分为PBS组、Ad组、Ad-ING4组、放疗组、Ad-ING4+放疗组。测量各...目的:研究腺病毒介导的肿瘤生长抑制因子4(inhibitor of growth family 4,ING4)联合放疗对肺腺癌SPC-A1细胞移植瘤生长的抑制作用。方法:制备SPC-A1细胞荷瘤小鼠模型,随机分为PBS组、Ad组、Ad-ING4组、放疗组、Ad-ING4+放疗组。测量各组荷瘤小鼠移植瘤的体积变化,治疗15 d后摘取瘤块,称质量并计算抑瘤率;H-E染色观察瘤体组织细胞的形态学变化,免疫组化法检测瘤体组织中Bax、caspase-3、Bcl-2、VEGF等因子的表达。结果:治疗后第15天SPC-A1移植瘤体积:Ad-ING4组为(1 136.03±151.58)mm3、单纯放疗组为(1 035.67±86.27)mm3、Ad-ING4+放疗组为(743.84±109.06)mm3,联合组可有效抑制肿瘤生长(P<0.01);此外,联合组抑瘤率也显著高于单纯Ad-ING4组或放疗组(69.62%vs 33.17%、35.41%,P<0.01),呈现放疗增敏协同作用(Q=1.22)。免疫组化结果显示,Ad-ING4及其联合放疗组能明显上调Bax、caspase-3等蛋白的表达,下调Bcl-2、VEGF等蛋白的表达,且Ad-ING4+放疗组对这些蛋白表达的调节作用强于Ad-ING4组、单纯放疗组(P<0.01)。结论:Ad-ING4联合放疗可有效抑制肺腺癌SPC-A1细胞移植瘤的生长。展开更多
文摘Objective:There has been an increasing interest in recent years in the role of stem cells.With an extensive understanding of their biology,a major role for stem cells in the malignant process has been proposed and the existence of cancer stem cells(CSCs) has been confirmed in hematopoietic malignancies and solid organ malignancies including brain cancer,breast,prostate,colon,and pancreatic cancer.Lung cancer is the leading cause of cancer mortality in most large cities of China.It is possible that lung cancer contains cancer stem cells responsible for its malignancy.The aim of this study is to identify,characterize and enrich the CSC population that drives and maintains lung adenocarcinoma growth and metastasis.Methods:Side population(SP) cell analysis and sorting were applied on human lung adenocarcinoma cell line and an attempt to further enrich them by preliminary serum-free culture before fluorescence activated cell sorting(FACS) was done.Stem cell properties of SP cells were evaluated by their proliferative index,colony-forming efficiency,tumorigenic potential,bi-differentiation capacity and the expression of common stem cell surface markers.Results:Lung cancer cells could grow in a serum-free Medium(SFM) as non-adherent spheres similar to neurospheres or mammospheres.The proportion of SP cells in cell spheres was significantly higher than that in cells grown as monolayers.SP cells had a greater proliferative index,a higher colony-forming efficiency and a greater ability to form tumor in vivo.SP cells were both CCA positive and SP-C positive while non-SP cells were only SP-C positive.Flow cytometric analysis of cell phenotype showed that SP cells expressed CD133 and CD44,the common cell surface markers of cancer stem cells,while non-SP cells only expressed CD44.Conclusion:SP cells existed in human lung adenocarcinoma cell lines and they could be further enriched by preliminary serum-free culture before FACS sorting.SP cells possessed the properties of cancer stem cells.
文摘目的:研究腺病毒介导的肿瘤生长抑制因子4(inhibitor of growth family 4,ING4)联合放疗对肺腺癌SPC-A1细胞移植瘤生长的抑制作用。方法:制备SPC-A1细胞荷瘤小鼠模型,随机分为PBS组、Ad组、Ad-ING4组、放疗组、Ad-ING4+放疗组。测量各组荷瘤小鼠移植瘤的体积变化,治疗15 d后摘取瘤块,称质量并计算抑瘤率;H-E染色观察瘤体组织细胞的形态学变化,免疫组化法检测瘤体组织中Bax、caspase-3、Bcl-2、VEGF等因子的表达。结果:治疗后第15天SPC-A1移植瘤体积:Ad-ING4组为(1 136.03±151.58)mm3、单纯放疗组为(1 035.67±86.27)mm3、Ad-ING4+放疗组为(743.84±109.06)mm3,联合组可有效抑制肿瘤生长(P<0.01);此外,联合组抑瘤率也显著高于单纯Ad-ING4组或放疗组(69.62%vs 33.17%、35.41%,P<0.01),呈现放疗增敏协同作用(Q=1.22)。免疫组化结果显示,Ad-ING4及其联合放疗组能明显上调Bax、caspase-3等蛋白的表达,下调Bcl-2、VEGF等蛋白的表达,且Ad-ING4+放疗组对这些蛋白表达的调节作用强于Ad-ING4组、单纯放疗组(P<0.01)。结论:Ad-ING4联合放疗可有效抑制肺腺癌SPC-A1细胞移植瘤的生长。